16E Stock Overview
A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Episurf Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0001 |
| 52 Week High | SEK 0.13 |
| 52 Week Low | SEK 0.0001 |
| Beta | 1.03 |
| 11 Month Change | 0% |
| 3 Month Change | -98.25% |
| 1 Year Change | -99.83% |
| 33 Year Change | -99.98% |
| 5 Year Change | -99.89% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 16E | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -94.1% | -3.6% | -2.2% |
| 1Y | -99.8% | -3.5% | 13.3% |
Return vs Industry: 16E underperformed the German Medical Equipment industry which returned -2.7% over the past year.
Return vs Market: 16E underperformed the German Market which returned 13.6% over the past year.
Price Volatility
| 16E volatility | |
|---|---|
| 16E Average Weekly Movement | 8,256.8% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 16E's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 16E's weekly volatility has increased from 6400% to 8257% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 26 | Pal Ryfors | episurf.com |
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Episurf Medical AB (publ) Fundamentals Summary
| 16E fundamental statistics | |
|---|---|
| Market cap | €7.93m |
| Earnings (TTM) | -€6.84m |
| Revenue (TTM) | €1.07m |
7.4x
P/S Ratio-1.2x
P/E RatioIs 16E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 16E income statement (TTM) | |
|---|---|
| Revenue | SEK 12.50m |
| Cost of Revenue | SEK 51.50m |
| Gross Profit | -SEK 39.00m |
| Other Expenses | SEK 40.80m |
| Earnings | -SEK 79.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | -0.12 |
| Gross Margin | -312.00% |
| Net Profit Margin | -638.40% |
| Debt/Equity Ratio | 0% |
How did 16E perform over the long term?
See historical performance and comparison